Borrelia burgdorferi

Borrelia burgdorferi is a bacterial species of the spirochete class of the genus Borrelia. It is well-known for being the causative agent of Lyme disease, which is the most common tick-borne disease in the North American and European continents.
Taxonomy[edit]
Borrelia burgdorferi belongs to the Borrelia genus, which is part of the larger Spirochaetes phylum. The genus Borrelia is further divided into three groups, with Borrelia burgdorferi being part of the Borrelia burgdorferi sensu lato complex.
Morphology[edit]
Borrelia burgdorferi is a Gram-negative, spiral-shaped bacterium. It is highly motile due to the presence of flagella located within the periplasmic space.
Pathogenesis[edit]
Borrelia burgdorferi is transmitted to humans through the bite of infected Ixodes ticks. Once in the bloodstream, the bacterium can disseminate to various tissues, causing a range of symptoms from fever and fatigue to more serious complications such as arthritis and neurological disorders.
Diagnosis and Treatment[edit]
Diagnosis of Borrelia burgdorferi infection is typically based on clinical symptoms and confirmed with serological testing. Treatment usually involves a course of antibiotics, with doxycycline and amoxicillin being the most commonly prescribed.
Prevention[edit]
Prevention of Borrelia burgdorferi infection primarily involves avoiding tick bites through the use of repellents, protective clothing, and checking for ticks after being in wooded or grassy areas.
See Also[edit]
|
This article is a stub You can help WikiMD by registering and expanding it with useful details, internal links, formatting, and categories. Editing is available only to registered and verified users. WikiMD is a comprehensive, free health and wellness encyclopedia. |
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian